Jefferies raised the firm’s price target on Exelon (EXC) to $57 from $52 and keeps a Buy rating on the shares. Less constructive investors have highlighted challenges in Illinois and Maryland, but overlook the strength of Pennsylvania, says the analyst, who argues that consensus does not appreciate a Pennsylvania PECO step-up around FY28. Exelon is “one of the best value opportunities at -10% discount but is out of favor,” the analyst contends.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXC:
